Christoforos K Vaxevanis (Christoforos Vaxevanis)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

Oncoimmunology

Journal for immunotherapy of cancer

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christoforos K Vaxevanis, Michael Bachmann, Barbara Seliger
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy. Journal for immunotherapy of cancer 12 (8) (2024)
Christoforos K Vaxevanis, Michael Bachmann, Barbara Seliger
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy. Journal for immunotherapy of cancer 12 (8) (2024)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Christoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, Diana Handke, Yuan Wang, Juliane Blümke, Reinhard Dummer, Chiara Massa, Barbara Seliger
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanoma. Clinical and translational medicine 12 (7) (2022)

Christoforos K Vaxevanis.css-eqlu8i{font-size:small;padding-left:4px;} (Christoforos Vaxevanis)

Publication Activity (10 Years)

Top Topics

Top Venues

Christoforos K Vaxevanis (Christoforos Vaxevanis)